Close Menu

NEW YORK – Qiagen on Tuesday reported a 26 percent year-over-year increase in its preliminary third quarter revenues, both at actual and constant exchange rates, driven by COVID-19 testing and improved customer demand for other products.

The company booked $481.3 million in preliminary revenues for the quarter, up from $382.7 million during the same quarter last year. In July, Qiagen had predicted Q3 sales to grow between 16 percent and 21 percent. Analysts, on average, expect revenues of $461 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.